Acetaminophen has long occupied an unusual place in pregnancy: when a pregnant woman has a fever, headache or significant pain, it is often the over-the-counter medicine she is told she can use. So a new study linking prenatal acetaminophen exposure with differences in the reproductive development of baby girls is bound to sound alarming.
The findings deserve attention—but not panic. The study found an association, not proof that acetaminophen caused the changes, and researchers do not know whether the differences seen in infancy will affect fertility later in life. Current medical guidance has not suddenly changed, and untreated fever and severe pain during pregnancy can carry risks of their own.
What the new study actually found
The Danish study, published in *Human Reproduction Open*, followed pregnant women whose acetaminophen use was tracked through repeated questionnaires and urine samples. Researchers later examined 302 infant girls at about three months old.
Compared with unexposed girls, prenatal exposure was associated with differences including smaller ovarian and uterine volume, fewer ovarian follicles in some exposure groups and changes in reproductive hormone markers. Researchers also looked at a separate cohort followed into adolescence and found some similar associations.
The peer-reviewed study is noteworthy because it is the first human study specifically designed to examine prenatal acetaminophen exposure in relation to markers of ovarian development in daughters.
The numbers sound dramatic—but they don’t tell us what happens later
Some of the reported differences are large enough to grab attention. But an ultrasound measurement at three months old is not a fertility diagnosis.
Researchers do not yet know whether girls with these developmental differences will have fewer children, difficulty becoming pregnant, earlier menopause or no meaningful reproductive consequences at all. Answering that question would require following them for years or decades.
Many exposed girls also had measurements similar to those of unexposed girls. The findings describe average differences between groups, not a predictable outcome for an individual child.
This was not a randomized trial
The study was observational. Women were not randomly assigned to take acetaminophen or avoid it, which means other differences between the groups could have influenced the results.
For example, women take acetaminophen because they have headaches, infections, fever, pain or other health problems. Researchers can adjust statistically for many factors, but observational research cannot eliminate every possible source of confounding.
That is why “linked with” is the accurate phrase here—not “acetaminophen damages ovaries.”
Why scientists were looking in the first place
The study did not emerge from nowhere. Animal research has raised questions about whether acetaminophen exposure during fetal development could influence the formation of ovarian follicles.
Girls are born with the finite pool of immature eggs from which future ovulation occurs. That makes fetal ovarian development biologically important and gives researchers a good reason to investigate potential exposures carefully.
But findings in animals do not automatically translate to humans, and early developmental markers in humans do not automatically translate into future infertility.
So should pregnant women stop taking acetaminophen?
That is not what the researchers are telling women to do.
Study leader Margit Bistrup Fischer specifically said women who used acetaminophen during pregnancy should not be alarmed. Current guidelines continue to consider acetaminophen an option for treating pain and fever during pregnancy when medically appropriate.
The safest response to a new study is not to replace one risk with another. High fever during pregnancy can itself be harmful, and severe untreated pain is not necessarily benign.
Save this article
Enter your email address and we'll send it straight to your inbox.
Pregnant women who need medication should discuss the appropriate drug, dose and duration with their healthcare provider rather than abruptly avoiding necessary treatment because of a headline.
Use medication for a reason—not automatically
The new findings do reinforce a sensible principle that applies to medication during pregnancy generally: use medicines when they are needed, at an appropriate dose, for an appropriate amount of time.
That does not mean enduring significant pain or fever to prove you can avoid medication. It means not taking any drug casually simply because it is available over the counter.
If you find yourself needing acetaminophen repeatedly or for prolonged periods during pregnancy, that is also a reason to talk with your clinician about what is causing the pain or fever and whether the treatment plan still makes sense.
Don’t substitute another pain reliever on your own
One especially important caution: do not assume ibuprofen, naproxen or another pain reliever is automatically a safer replacement during pregnancy.
Different medications carry different risks at different stages of pregnancy. The FDA has warned against NSAID use at 20 weeks of pregnancy or later unless specifically advised by a healthcare professional because of risks to fetal kidney function and amniotic fluid, among other concerns.
Medication decisions in pregnancy are about balancing risks—not finding a drug with absolutely none.
What this research should change right now
For most women, the immediate change should be awareness rather than fear.
The study gives researchers an important signal to investigate. It may eventually influence recommendations if larger studies reproduce the findings and long-term follow-up shows meaningful reproductive consequences.
For now, it is a reason for better research, not a reason for women who took Tylenol during pregnancy to assume they harmed their daughters.
Final word
Pregnancy creates a uniquely difficult standard for medication decisions because doing something can carry risk—and so can doing nothing.
This new study raises a legitimate scientific question about acetaminophen and female reproductive development. It does not answer the question women care about most: whether ordinary prenatal use actually changes a daughter’s future fertility or reproductive health.
Until we know more, the most responsible approach is neither “Tylenol is completely harmless” nor “pregnant women should never take it.” Use medication thoughtfully, involve your healthcare provider when you need it and resist turning an interesting association into a frightening certainty.
